Abstract

Coccidioidomycosis is an endemic fungal infection of the southwestern United States. Normally a self-limited infection in healthy hosts, coccidioidomycosis can become a serious complication in patients who have had solid organ transplantation. Among patients whose solid organ transplantation was complicated by coccidioidomycosis, the infection has a variety of clinical presentations. Disseminated disease is common and has substantial morbidity. Patients at risk for coccidioidal infection should be identified so that antifungal prophylactic therapy can be initiated. Treatment options include amphotericin B or azoles. Secondary prophylaxis is recommended because relapse is frequent.

Highlights

  • A review of the medical literature was conducted to summarize the reports of transplant recipients whose posttransplantation courses were complicated by coccidioidomycosis

  • Secondary prophylactic therapy is recommended because relapse is frequent

  • Many questions persist regarding coccidioidomycosis in transplantation; future studies should refine screening, prophylactic therapy, and treatment for these patients

Read more

Summary

Coccidioidomycosis in Solid Organ Transplantation

Coccidioidomycosis is an endemic fungal infection of the southwestern United States. A self-limited infection in healthy hosts, coccidioidomycosis can become a serious complication in patients who have had solid organ transplantation. Among patients whose solid organ transplantation was complicated by coccidioidomycosis, the infection has a variety of clinical presentations. Risk factors for disseminated disease include diabetes mellitus, pregnancy, male sex, race with dark pigmentation (African American, Filipino, Hispanic, and others), and immunodeficiency (such as HIV infection or organ transplantation) [1, 2]. In 1971, the death of a child due to disseminated coccidioidomycosis after renal transplantation prompted Murphey et al [4] to recommend that potential transplantation candidates with any evidence of prior coccidioidal infection should be excluded. Other authors have reiterated similar ideas [5] Despite these concerns, solid organ transplantation has flourished in locations of high endemicity for coccidioidomycosis. We review the current literature from a few transplant centers on coccidioidomycosis and solid organ transplantation

METHODS
RESULTS
Antifungal treatment
Septic arthritis
Died of coccidioidal meningitis
No of CDM cases
Lungs Transplant graft
Prophylaxis and Treatment
SUMMARY
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.